OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Membranous nephropathy: Mechanistic insights and therapeutic perspectives
Meng-Ru Hua, Yanlong Zhao, Junzheng Yang, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110317-110317
Closed Access | Times Cited: 15
Meng-Ru Hua, Yanlong Zhao, Junzheng Yang, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110317-110317
Closed Access | Times Cited: 15
Showing 15 citing articles:
Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan‐produced indole metabolites
Hua Miao, Yanni Wang, Xiao‐Yong Yu, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 1, pp. 162-179
Closed Access | Times Cited: 44
Hua Miao, Yanni Wang, Xiao‐Yong Yu, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 1, pp. 162-179
Closed Access | Times Cited: 44
The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis
Na Ren, Wenfeng Wang, Liang Zou, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Na Ren, Wenfeng Wang, Liang Zou, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Diosgenin protects against cationic bovine serum albumin-induced membranous glomerulonephritis by attenuating oxidative stress and renal inflammation via the NF-κB pathway
Shiyan Jia, Ruihua Si, Guangzhen Liu, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 285-295
Open Access | Times Cited: 7
Shiyan Jia, Ruihua Si, Guangzhen Liu, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 285-295
Open Access | Times Cited: 7
Bile acid metabolism in health and ageing-related diseases
Xiaojun Li, Chu Fang, Ruihua Zhao, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116313-116313
Closed Access | Times Cited: 7
Xiaojun Li, Chu Fang, Ruihua Zhao, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116313-116313
Closed Access | Times Cited: 7
Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy
Yanni Wang, Hua Miao, Xiao-Yong Yu, et al.
Free Radical Biology and Medicine (2023) Vol. 207, pp. 89-106
Closed Access | Times Cited: 16
Yanni Wang, Hua Miao, Xiao-Yong Yu, et al.
Free Radical Biology and Medicine (2023) Vol. 207, pp. 89-106
Closed Access | Times Cited: 16
Modified Huangqi Chifeng decoction alleviates podocyte injury on rat with experimental membranous nephropathy
Mei‐Ying Chang, Xiujie Shi, Bin Yang, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Mei‐Ying Chang, Xiujie Shi, Bin Yang, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
A Novel Classification Model Based on Hyperspectral Imaging for Predicting Response to Tacrolimus in Patients With Primary Membranous Nephropathy
Meijuan Sun, Wenqiang Zhang, Chongxuan Tian, et al.
Journal of Biophotonics (2025)
Closed Access
Meijuan Sun, Wenqiang Zhang, Chongxuan Tian, et al.
Journal of Biophotonics (2025)
Closed Access
Rituximab, tacrolimus, cyclophosphamide and cyclosporin in primary membranous nephropathy with nephrotic syndrome: comparison of safety profiles, effect on remission rate, 24-h urinary total protein, serum albumin, and serum creatinine levels using network meta-analysis
Ni Cai, Shuying Zhu, Jinjing Huang, et al.
International Urology and Nephrology (2025)
Closed Access
Ni Cai, Shuying Zhu, Jinjing Huang, et al.
International Urology and Nephrology (2025)
Closed Access
Serum uric acid level is associated with glomerular ischemic lesions in patients with primary membranous nephropathy: an analytical, cross-sectional study
Yamin Yu, Juan Zheng, Jie Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Yamin Yu, Juan Zheng, Jie Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Membranous nephropathy: pathogenesis and treatments
M.M. Wang, Jingjuan Yang, Xin Fang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3
M.M. Wang, Jingjuan Yang, Xin Fang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3
Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment
Bo Huang, Zitong Zhang, Wendong Sui, et al.
Genomics (2024) Vol. 116, Iss. 2, pp. 110796-110796
Open Access | Times Cited: 2
Bo Huang, Zitong Zhang, Wendong Sui, et al.
Genomics (2024) Vol. 116, Iss. 2, pp. 110796-110796
Open Access | Times Cited: 2
Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines
Yang Yang, Kaiqi Cheng, Gaosi Xu
European Journal of Pharmacology (2024) Vol. 982, pp. 176928-176928
Closed Access | Times Cited: 2
Yang Yang, Kaiqi Cheng, Gaosi Xu
European Journal of Pharmacology (2024) Vol. 982, pp. 176928-176928
Closed Access | Times Cited: 2
Moshen granule ameliorates membranous nephropathy by regulating NF-ƙB/Nrf2 pathways via aryl hydrocarbon receptor signalling
Shixing Ma, Xiaojun Li, Tingting Duan, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e20019-e20019
Open Access | Times Cited: 5
Shixing Ma, Xiaojun Li, Tingting Duan, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e20019-e20019
Open Access | Times Cited: 5
Novel therapeutic approaches in the management of chronic kidney disease: a narrative review
Panagiotis Theofilis, Aikaterini Vordoni, Rigas Kalaitzidis
Postgraduate Medicine (2023) Vol. 135, Iss. 6, pp. 543-550
Closed Access | Times Cited: 2
Panagiotis Theofilis, Aikaterini Vordoni, Rigas Kalaitzidis
Postgraduate Medicine (2023) Vol. 135, Iss. 6, pp. 543-550
Closed Access | Times Cited: 2
Research Progress on Combination of Chinese and Western Medicine in the Treatment of Primary Membranous Nephropathy
爱丽 戴
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 2502-2506
Closed Access
爱丽 戴
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 2502-2506
Closed Access
New insight into the role of exosomes in idiopathic membrane nephropathy
JIANHONG LIU, Kai He, Han Wang, et al.
Biocell (2024) Vol. 48, Iss. 1, pp. 21-32
Open Access
JIANHONG LIU, Kai He, Han Wang, et al.
Biocell (2024) Vol. 48, Iss. 1, pp. 21-32
Open Access
